DYAI
DYAI
NASDAQ · Biotechnology

Dyadic International Inc

$0.85
+0.00 (+0.26%)
As of Feb 8, 2:22 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 4.67M 4.58M 5.07M
Net Income -1,188,285 -1,151,647 -1,307,679
EPS
Profit Margin -25.5% -25.2% -25.8%
Rev Growth -5.2% +24.2% +16.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 11.47M 10.08M 8.74M
Total Equity 15.98M 17.40M 17.52M
D/E Ratio 0.72 0.58 0.50
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -1,613,290 -1,556,423 -1,763,687
Free Cash Flow -995,176 -1,101,967 -1,220,171